These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 17212106)

  • 1. [Analysis of long-term (5-year) survival in patients with metastatic breast cancer to the liver].
    Kan N
    Gan To Kagaku Ryoho; 2006 Nov; 33(12):1780-4. PubMed ID: 17212106
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patterns of relapse and metastatic spread in HER2-overexpressing breast cancer according to estrogen receptor status.
    Park YH; Lee S; Cho EY; Choi YL; Lee JE; Nam SJ; Yang JH; Ahn JS; Im YH
    Cancer Chemother Pharmacol; 2010 Aug; 66(3):507-16. PubMed ID: 19956951
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metastatic breast cancer with liver metastases: a registry analysis of clinicopathologic, management and outcome characteristics of 500 women.
    Pentheroudakis G; Fountzilas G; Bafaloukos D; Koutsoukou V; Pectasides D; Skarlos D; Samantas E; Kalofonos HP; Gogas H; Pavlidis N
    Breast Cancer Res Treat; 2006 Jun; 97(3):237-44. PubMed ID: 16322882
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liver-directed surgery for metastatic squamous cell carcinoma to the liver: results of a multi-center analysis.
    Pawlik TM; Gleisner AL; Bauer TW; Adams RB; Reddy SK; Clary BM; Martin RC; Scoggins CR; Tanabe KK; Michaelson JS; Kooby DA; Staley CA; Schulick RD; Vauthey JN; Abdalla EK; Curley SA; Choti MA; Elias D
    Ann Surg Oncol; 2007 Oct; 14(10):2807-16. PubMed ID: 17551795
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Curative liver resection for metastatic breast cancer.
    Maksan SM; Lehnert T; Bastert G; Herfarth C
    Eur J Surg Oncol; 2000 Apr; 26(3):209-12. PubMed ID: 10753531
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic factors for patients with liver metastases from breast cancer.
    Eichbaum MH; Kaltwasser M; Bruckner T; de Rossi TM; Schneeweiss A; Sohn C
    Breast Cancer Res Treat; 2006 Mar; 96(1):53-62. PubMed ID: 16319993
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical characteristics and prognosis of triple-negative breast cancer: a report of 305 cases].
    Yuan ZY; Wang SS; Gao Y; Su ZY; Luo WB; Guan ZZ
    Ai Zheng; 2008 Jun; 27(6):561-5. PubMed ID: 18570725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinicopathological features and outcome of hepatic resection for liver metastasis from gastric cancer.
    Saiura A; Umekita N; Inoue S; Maeshiro T; Miyamoto S; Matsui Y; Asakage M; Kitamura M
    Hepatogastroenterology; 2002; 49(46):1062-5. PubMed ID: 12143202
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Retrospective analysis of 98 cases of breast cancer with liver metastasis].
    Zhu MQ; Zhang DS; Su ZY; Shi YX; Peng RJ; Zhou NN; Liu DG; Jiang WQ
    Ai Zheng; 2007 Apr; 26(4):423-6. PubMed ID: 17430666
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Different prognostic value of cytokeratin-19 mRNA positive circulating tumor cells according to estrogen receptor and HER2 status in early-stage breast cancer.
    Ignatiadis M; Xenidis N; Perraki M; Apostolaki S; Politaki E; Kafousi M; Stathopoulos EN; Stathopoulou A; Lianidou E; Chlouverakis G; Sotiriou C; Georgoulias V; Mavroudis D
    J Clin Oncol; 2007 Nov; 25(33):5194-202. PubMed ID: 17954712
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The triple negative paradox: primary tumor chemosensitivity of breast cancer subtypes.
    Carey LA; Dees EC; Sawyer L; Gatti L; Moore DT; Collichio F; Ollila DW; Sartor CI; Graham ML; Perou CM
    Clin Cancer Res; 2007 Apr; 13(8):2329-34. PubMed ID: 17438091
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HER2-positive circulating tumor cells indicate poor clinical outcome in stage I to III breast cancer patients.
    Wülfing P; Borchard J; Buerger H; Heidl S; Zänker KS; Kiesel L; Brandt B
    Clin Cancer Res; 2006 Mar; 12(6):1715-20. PubMed ID: 16551854
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical course of breast cancer patients with metastases limited to the liver treated with chemotherapy.
    Er O; Frye DK; Kau SW; Broglio K; Valero V; Hortobagyi GN; Arun B
    Cancer J; 2008; 14(1):62-8. PubMed ID: 18303485
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term survival after an aggressive surgical approach in patients with breast cancer hepatic metastases.
    Vlastos G; Smith DL; Singletary SE; Mirza NQ; Tuttle TM; Popat RJ; Curley SA; Ellis LM; Roh MS; Vauthey JN
    Ann Surg Oncol; 2004 Sep; 11(9):869-74. PubMed ID: 15342348
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Evaluation of multimodality therapy for synchronous liver metastases of gastric cancer].
    Sasaki H; Ninomiya M; Yano S; Umeoka T; Harano M; Aoki H; Onoda T; Shiozaki S; Ohno S; Higaki K; Takakura N
    Gan To Kagaku Ryoho; 2004 Oct; 31(11):1924-6. PubMed ID: 15553761
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surgical and chemotherapeutic treatment of hepatic metastases from carcinoma of the breast.
    Elias D; Lasser P; Spielmann M; May-Levin F; el Malt O; Thomas H; Mouriesse H
    Surg Gynecol Obstet; 1991 Jun; 172(6):461-4. PubMed ID: 2035135
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term characteristics of 5-year survivors after liver resection for colorectal metastases.
    Tanaka K; Shimada H; Ueda M; Matsuo K; Endo I; Togo S
    Ann Surg Oncol; 2007 Apr; 14(4):1336-46. PubMed ID: 17235718
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pulmonary metastases of breast cancer. When is resection indicated?
    Welter S; Jacobs J; Krbek T; Tötsch M; Stamatis G
    Eur J Cardiothorac Surg; 2008 Dec; 34(6):1228-34. PubMed ID: 18824371
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disparities in the survival improvement of recurrent breast cancer.
    Anan K; Mitsuyama S; Koga K; Tanabe R; Saimura M; Tanabe Y; Watanabe M; Suehara N; Matsunaga H; Nishihara K; Abe Y; Nakano T; Tamae K; Ono M; Toyoshima S
    Breast Cancer; 2010; 17(1):48-55. PubMed ID: 19350357
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The utility of estrogen receptor, progesterone receptor, and Her-2/neu status to predict survival in patients undergoing hepatic resection for breast cancer metastases.
    Martinez SR; Young SE; Giuliano AE; Bilchik AJ
    Am J Surg; 2006 Feb; 191(2):281-3. PubMed ID: 16442961
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.